Navigation Links
Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten 'Notable People in R&D'
Date:3/23/2010

CINCINNATI, March 23 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Drew Kilpatrick, PhD, Director, Global Safety and Pharmacovigilance, has been named one of ten "Notable People in R&D" by leading industry publication R&D Directions.  Dr. Kilpatrick was selected based on his pioneering work in developing TrialEAS™, a practical Web-based solution that enables independent adjudication of clinical endpoints and assists investigators in selecting appropriate patients for enrollment into clinical studies.  TrialEAS™ recently was honored as the "Best Technological Development in Clinical Trials – Software Solution" at the 2009 Clinical Research Excellence Awards sponsored by Good Clinical Practice Journal.

"We are so pleased that R&D Directions has recognized the groundbreaking and innovative nature of the work completed by Dr. Kilpatrick and his team," said Stephen Cutler, PhD, Senior Vice President and Chief Operating Officer.  "As regulatory authorities increase requirements for endpoint driven studies to confirm morbidity, mortality or safety, it becomes ever more crucial to develop solutions that reduce costs within the clinical development process without compromising patient safety or clinical judgment.  With TrialEAS™, Dr. Kilpatrick's team has introduced a versatile Web-based solution that fulfills these requirements."    


'/>"/>
SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
2. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
3. Kendle Launches New Global Biostatistics Infrastructure
4. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
5. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
6. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
7. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
8. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
9. Kensey Nash Corporation Announces the Addition of Donald Morel, Jr., Ph.D. to Its Board of Directors
10. ThermalTherapeutic Systems, Inc. Announces the Addition of Former MEDRAD Executive Alan Hirschman, PhD to the Board of Directors
11. Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Ohio , Jan. 15, 2014  A novel wearable injector ... easy and painless for patients to self-inject prescription drugs in ... disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... to grow to $220B by 2018, according to analysts.   Many ...
(Date:1/14/2014)... AUSTIN, Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... report results for the fourth quarter of 2013 on Monday, ... scheduled for release after the close of trading. ... a conference call to discuss the operating highlights and financial ...
(Date:1/14/2014)... Calif. , Jan. 14, 2014 The Brandeis Medical Center, ... Angeles a premier and affordable laser tattoo removal experience ... Dr. Brandeis, focus is in providing high quality cosmetic services with ... patients. " Southern California has seen ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... 2011 Omeros Corporation (Nasdaq: OMER ) today ... Regents of the University of California to a new series ... advance in the control of surgical and traumatic bleeding. ... represents a potential life-saving treatment for patients. With the withdrawal ...
... 5, 2011 CutisPharma, Inc. announced the introduction ... Mary,s Mouthwash compounding kits. These products complete the ... line already includes FIRST® - Mouthwash BLM, and ... FIRST® - Duke,s Mouthwash are comparable to those ...
Cached Medicine Technology:Omeros Licenses Novel Antifibrinolytic Agents 2Omeros Licenses Novel Antifibrinolytic Agents 3Omeros Licenses Novel Antifibrinolytic Agents 4CutisPharma Launches New Prescription Mouthwash Kits Expanding Product Line 2
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
(Date:4/17/2014)... Colo. (April 17, 2014) Two recent papers ... researcher and colleagues may help scientists develop treatments ... Yellow fever, Japanese encephalitis and other disease-causing flaviviruses. ... biochemistry and molecular genetics at the School of ... Howard Hughes Medical Institute, and colleagues recently published ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... Boston University School of Medicine (BUSM) have discovered ... in an experimental model. The findings, reported in ... Abuse , may lead to more effective treatments ... one of the leading causes of illness and ... economic impact by limiting the productivity of workers ...
(Date:4/17/2014)... NEW YORK (17 April 2014) Population Council scientists and ... is safe, stable, and can prevent the transmission of ... and rectum in animals: HIV, herpes simplex virus 2 ... provides the first data that the gel is effective ... of efficacy in the vagina against all three viruses ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... Dr Mukesh Haikerwal, today congratulated the Government on a ... // with the AMA, and which delivers for patients. ... that the draconian conditions and red tape associated with ... ,'The Government has agreed that the expertise in prescribing ...
... especially the mentally-ill patients and their caregivers. The speech revived ... which would permit the use of obligatory powers to enable ... present ‘treatability test’. ,The infamous ‘Bournewood gap’ is ... of the new bill, which will seek to improve the ...
... banned the use of hookah, or hubble-bubble, in the Pakistani ... were spoiling the younger// generation. ,A way of ... South Asia and the Middle East, the hookah, known as ... and motels in Pakistan, The Daily Times said. ...
... more delays in getting the lab results! - Says ... from University of Georgia has developed a diagnostic test using ... influenza, HIV, RSV etc., in just 60 seconds or even ... technique – which is detailed in the November issue of ...
... that about one in 10 U.S. adults suffer chronic pain that ... Americans have increased to a record average of just short of ... from the Centers for Disease Control and Prevention. ,The ... 80 years and nearly 75 for males. The gap in life ...
... know that they shouldn't smoke or be around smokers ... at a young age. In addition, a new research ... could develop serious liver injuries due to the effects ... research performed at Washington University School of Medicine in ...
Cached Medicine News:Health News:Government Strikes Right Balance with PBS Reform 2Health News:Nanotechnology Used For Detecting Viruses 2Health News:Nanotechnology Used For Detecting Viruses 3Health News:Non-Steroidal Anti-Inflammatory Drugs Can Cause Liver Damages 2Health News:Non-Steroidal Anti-Inflammatory Drugs Can Cause Liver Damages 3
... PLUS pachometers are acknowledged to be the ... pachometers available. These benefits are due to ... and smallest tip footprint available coupled with ... for every displayed reading. Thus corneal thickness ...
... versatile and uncomplicated use of the Leica ... obtained make it the instrument of choice ... cryostat applications. The open top stainless steel ... accessible and offers ample space for convenient ...
... the new style of Bright cryostat. ... OTF/AS cryostat, the new OTF5000 incorporates ... ever-reliable and powerful 5040 microtome. A ... package deals makes the range of ...
... The Leica TP1020 product family are ... a perfect combination of approved technology with ... processing and maximum safety for tissues at ... engineering design based on proven precision mechanics ...
Medicine Products: